Pelitinib [257933-82-7]
P1845
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NamePelitinib [257933-82-7]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥98%
- FormatInsoluble in water. Soulble in DMSO (≥13 mg/mL).
- Scientific DescriptionEGFR inhibitor.; EKB-569
- Storage InstructionAmbient
- UNSPSC12352200
References
- Aravindan N, Aravindan S, Herman TS, et al. EGFR tyrosine kinase inhibitor pelitinib regulates radiation-induced p65-dependent telomerase activation in squamous cell carcinoma. Radiat Res. 2013 Mar;179(3):304-12. PMID: 23379415. Kim H, Lim HY. Novel EGFR-TK inhibitor EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT and MAPK pathways. J Korean Med Sci. 2011 Dec;26(12):1563-8. PMID: 22147992. Yoshimura N, Kudoh S, Kimura T, et al. EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib. Lung Cancer. 2006 Mar;51(3):363-8. PMID: 16364494.